| Fatty acid synthase as a potential therapeutic target in cancer R Flavin, S Peluso, PL Nguyen, M Loda Future oncology 6 (4), 551-562, 2010 | 673 | 2010 |
| Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells J Li, P Smyth, R Flavin, S Cahill, K Denning, S Aherne, SM Guenther, ... BMC biotechnology 7, 1-6, 2007 | 458 | 2007 |
| Potential role of miR-9 and miR-223 in recurrent ovarian cancer A Laios, S O'Toole, R Flavin, C Martin, L Kelly, M Ring, SP Finn, C Barrett, ... Molecular cancer 7, 1-14, 2008 | 390 | 2008 |
| The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis A Pettersson, RE Graff, SR Bauer, MJ Pitt, RT Lis, EC Stack, NE Martin, ... Cancer epidemiology, biomarkers & prevention 21 (9), 1497-1509, 2012 | 357 | 2012 |
| Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors V Vaira, G Fedele, S Pyne, E Fasoli, G Zadra, D Bailey, E Snyder, ... Proceedings of the National Academy of Sciences 107 (18), 8352-8356, 2010 | 310 | 2010 |
| MYC regulation of a “poor-prognosis” metastatic cancer cell state A Wolfer, BS Wittner, D Irimia, RJ Flavin, M Lupien, RN Gunawardane, ... Proceedings of the National Academy of Sciences 107 (8), 3698-3703, 2010 | 210 | 2010 |
| Metabolic alterations and targeted therapies in prostate cancer R Flavin, G Zadra, M Loda The Journal of pathology 223 (2), 284-295, 2011 | 209 | 2011 |
| A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer TU Ahearn, A Pettersson, EM Ebot, T Gerke, RE Graff, CL Morais, ... Journal of the National Cancer Institute 108 (2), djv346, 2016 | 201 | 2016 |
| Vitamin D receptor protein expression in tumor tissue and prostate cancer progression WK Hendrickson, R Flavin, JL Kasperzyk, M Fiorentino, F Fang, R Lis, ... Journal of clinical oncology 29 (17), 2378-2385, 2011 | 172 | 2011 |
| mRNA expression signature of Gleason grade predicts lethal prostate cancer KL Penney, JA Sinnott, K Fall, Y Pawitan, Y Hoshida, P Kraft, JR Stark, ... Journal of Clinical Oncology 29 (17), 2391-2396, 2011 | 164 | 2011 |
| Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer JL Kasperzyk, SP Finn, R Flavin, M Fiorentino, R Lis, WK Hendrickson, ... Cancer epidemiology, biomarkers & prevention 22 (12), 2354-2363, 2013 | 145 | 2013 |
| Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model S Cahill, P Smyth, SP Finn, K Denning, R Flavin, EM O'Regan, J Li, ... Molecular Cancer 5, 1-12, 2006 | 143* | 2006 |
| Cetuximab response of lung cancer–derived EGF receptor mutants is associated with asymmetric dimerization J Cho, L Chen, N Sangji, T Okabe, K Yonesaka, JM Francis, RJ Flavin, ... Cancer research 73 (22), 6770-6779, 2013 | 111 | 2013 |
| Potentially important microRNA cluster on chromosome 17p13. 1 in primary peritoneal carcinoma RJ Flavin, PC Smyth, A Laios, SA O'toole, C Barrett, SP Finn, S Russell, ... Modern Pathology 22 (2), 197-205, 2009 | 111 | 2009 |
| Improved RNA quality and TaqMan®Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials J Li, P Smyth, S Cahill, K Denning, R Flavin, S Aherne, M Pirotta, ... BMC biotechnology 8, 1-11, 2008 | 109 | 2008 |
| Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients RJ Flavin, PC Smyth, SP Finn, A Laios, SA O'toole, C Barrett, M Ring, ... Modern Pathology 21 (6), 676-684, 2008 | 109 | 2008 |
| Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis MM Pomerantz, Y Shrestha, RJ Flavin, MM Regan, KL Penney, LA Mucci, ... PLoS genetics 6 (11), e1001204, 2010 | 108 | 2010 |
| Mesenchymal stem cell‐mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer RM Dwyer, J Ryan, RJ Havelin, JC Morris, BW Miller, Z Liu, R Flavin, ... Stem cells 29 (7), 1149-1157, 2011 | 104 | 2011 |
| Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG A Pettersson, RT Lis, A Meisner, R Flavin, EC Stack, M Fiorentino, S Finn, ... Journal of the National Cancer Institute 105 (24), 1881-1890, 2013 | 98 | 2013 |
| MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer B Benassi, R Flavin, L Marchionni, S Zanata, Y Pan, D Chowdhury, ... Cancer discovery 2 (3), 236-247, 2012 | 97 | 2012 |
